Plasma myelin basic protein assay using Gilford enzyme immunoassay cuvettes

Area of Science:

• Neurochemistry
• Clinical Diagnostics
• Biochemical Assays

Background:

• Myelin basic protein (MBP) levels in body fluids are crucial indicators of demyelination.
• Previous work established a competitive enzyme immunoassay for MBP.
• Clinical application requires adaptation for human plasma and efficient data processing.

Purpose of the Study:

• To adapt a competitive enzyme immunoassay for quantifying myelin basic protein (MBP) in human plasma.
• To optimize routine data processing for this assay.
• To evaluate assay performance using a commercial cuvette system.

Main Methods:

• Adaptation of a previously developed competitive enzyme immunoassay for human plasma.
• Utilized a commercially available cuvette system, comparing it to microtitre plates.
• Implemented permuted sample replicate arrangements for consistent results.
• Employed regression analysis with a three-parameter non-linear equation or logit/log transformation for dose interpolation.

Main Results:

• The assay was successfully adapted for human plasma analysis.
• A commercial cuvette system demonstrated advantages over microtitre plates.
• Specific sample replicate arrangements were necessary for assay consistency.
• Standard curves could be accurately analyzed using non-linear regression or logit/log transformations.

Conclusions:

• The adapted assay is suitable for routine measurement of myelin basic protein in human plasma.
• This assay holds significant potential as a clinical tool for diagnosing demyelination.
• Optimization of assay methodology and data processing enhances its clinical utility.